JP2018530336A5 - - Google Patents

Download PDF

Info

Publication number
JP2018530336A5
JP2018530336A5 JP2018518438A JP2018518438A JP2018530336A5 JP 2018530336 A5 JP2018530336 A5 JP 2018530336A5 JP 2018518438 A JP2018518438 A JP 2018518438A JP 2018518438 A JP2018518438 A JP 2018518438A JP 2018530336 A5 JP2018530336 A5 JP 2018530336A5
Authority
JP
Japan
Prior art keywords
cell
cells
nucleic acid
perv
porcine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018518438A
Other languages
English (en)
Japanese (ja)
Other versions
JP7059468B2 (ja
JP2018530336A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/055916 external-priority patent/WO2017062723A1/en
Publication of JP2018530336A publication Critical patent/JP2018530336A/ja
Publication of JP2018530336A5 publication Critical patent/JP2018530336A5/ja
Priority to JP2021034493A priority Critical patent/JP7144122B2/ja
Priority to JP2021196238A priority patent/JP7420439B2/ja
Application granted granted Critical
Publication of JP7059468B2 publication Critical patent/JP7059468B2/ja
Priority to JP2022076779A priority patent/JP7473136B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018518438A 2015-10-08 2016-10-07 多重ゲノム編集 Active JP7059468B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2021034493A JP7144122B2 (ja) 2015-10-08 2021-03-04 多重ゲノム編集
JP2021196238A JP7420439B2 (ja) 2015-10-08 2021-12-02 多重ゲノム編集
JP2022076779A JP7473136B2 (ja) 2015-10-08 2022-05-06 多重ゲノム編集

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562239239P 2015-10-08 2015-10-08
US62/239,239 2015-10-08
PCT/US2016/055916 WO2017062723A1 (en) 2015-10-08 2016-10-07 Multiplexed genome editing

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2021034493A Division JP7144122B2 (ja) 2015-10-08 2021-03-04 多重ゲノム編集
JP2021196238A Division JP7420439B2 (ja) 2015-10-08 2021-12-02 多重ゲノム編集

Publications (3)

Publication Number Publication Date
JP2018530336A JP2018530336A (ja) 2018-10-18
JP2018530336A5 true JP2018530336A5 (enExample) 2019-12-12
JP7059468B2 JP7059468B2 (ja) 2022-04-26

Family

ID=58488520

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2018518438A Active JP7059468B2 (ja) 2015-10-08 2016-10-07 多重ゲノム編集
JP2021034493A Active JP7144122B2 (ja) 2015-10-08 2021-03-04 多重ゲノム編集
JP2021196238A Active JP7420439B2 (ja) 2015-10-08 2021-12-02 多重ゲノム編集
JP2022076779A Active JP7473136B2 (ja) 2015-10-08 2022-05-06 多重ゲノム編集

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2021034493A Active JP7144122B2 (ja) 2015-10-08 2021-03-04 多重ゲノム編集
JP2021196238A Active JP7420439B2 (ja) 2015-10-08 2021-12-02 多重ゲノム編集
JP2022076779A Active JP7473136B2 (ja) 2015-10-08 2022-05-06 多重ゲノム編集

Country Status (15)

Country Link
US (6) US10959413B2 (enExample)
EP (2) EP4491732A3 (enExample)
JP (4) JP7059468B2 (enExample)
KR (2) KR102729669B1 (enExample)
CN (2) CN108513580A (enExample)
AU (2) AU2016335698B2 (enExample)
CA (1) CA3001314A1 (enExample)
CL (1) CL2018000902A1 (enExample)
CO (1) CO2018004763A2 (enExample)
IL (2) IL297017A (enExample)
MX (2) MX2018004263A (enExample)
NZ (1) NZ741778A (enExample)
SA (2) SA518391294B1 (enExample)
WO (1) WO2017062723A1 (enExample)
ZA (1) ZA201802461B (enExample)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013066438A2 (en) 2011-07-22 2013-05-10 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
IL308158A (en) * 2012-12-17 2023-12-01 Harvard College Rna-guided human genome engineering
US9163284B2 (en) 2013-08-09 2015-10-20 President And Fellows Of Harvard College Methods for identifying a target site of a Cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
US20150166984A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting alpha-antitrypsin point mutations
AU2015298571B2 (en) 2014-07-30 2020-09-03 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins
EP3221457B1 (en) 2014-11-21 2019-03-20 Regeneron Pharmaceuticals, Inc. Methods and compositions for targeted genetic modification using paired guide rnas
AU2016335698B2 (en) * 2015-10-08 2022-12-01 President And Fellows Of Harvard College Multiplexed genome editing
WO2017070632A2 (en) 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
AU2016365720B2 (en) 2015-12-07 2020-11-26 Arc Bio, Llc Methods and compositions for the making and using of guide nucleic acids
WO2017109177A1 (en) 2015-12-24 2017-06-29 Selexis S.A. Improved eukaryotic cells for protein manufacturing and methods of making them
SG10202102885UA (en) 2016-05-20 2021-05-28 Regeneron Pharma Methods for breaking immunological tolerance using multiple guide rnas
WO2018027078A1 (en) 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
AU2017308889B2 (en) 2016-08-09 2023-11-09 President And Fellows Of Harvard College Programmable Cas9-recombinase fusion proteins and uses thereof
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
KR20240007715A (ko) 2016-10-14 2024-01-16 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵염기 에디터의 aav 전달
US11634721B2 (en) * 2016-12-14 2023-04-25 Dow Agrosciences Llc Reconstruction of site specific nuclease binding sites
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
KR20190123328A (ko) 2017-03-09 2019-10-31 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 암 백신
WO2018165504A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Suppression of pain by gene editing
CN110914310A (zh) 2017-03-10 2020-03-24 哈佛大学的校长及成员们 胞嘧啶至鸟嘌呤碱基编辑器
IL306092A (en) 2017-03-23 2023-11-01 Harvard College Nucleic base editors that include nucleic acid programmable DNA binding proteins
CN116732106A (zh) * 2017-04-20 2023-09-12 E开创生物技术股份有限公司 产生基因修改的动物的方法
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
CN107254551B (zh) * 2017-06-06 2020-04-07 中国人民解放军军事科学院军事医学研究院 鉴定和选育PERV-pol基因缺陷型五指山小型猪新品系的方法
EP3635114B1 (en) * 2017-06-07 2024-11-06 Arc Bio, LLC Creation and use of guide nucleic acids
EP3658573A1 (en) 2017-07-28 2020-06-03 President and Fellows of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace)
EP3676376B1 (en) 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
CA3082251A1 (en) 2017-10-16 2019-04-25 The Broad Institute, Inc. Uses of adenosine base editors
US12406749B2 (en) 2017-12-15 2025-09-02 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
WO2019226953A1 (en) 2018-05-23 2019-11-28 The Broad Institute, Inc. Base editors and uses thereof
EP3820495A4 (en) 2018-07-09 2022-07-20 The Broad Institute Inc. RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
KR102158428B1 (ko) 2018-08-16 2020-09-22 (주)라트바이오 인위적 뉴클레아제를 생산하는 형질전환 배아 및 형질전환 동물의 제작 방법
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
WO2020191241A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
WO2020214842A1 (en) 2019-04-17 2020-10-22 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
CN110358766A (zh) * 2019-06-10 2019-10-22 云南农业大学 一种基于全基因组CRISPR/Cas9文库筛选异种移植抗原基因的方法
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
CN111549060A (zh) * 2020-05-07 2020-08-18 西南大学 一种真核生物CRISPR/Cas9全基因组编辑细胞文库及构建方法
CN111534541A (zh) * 2020-05-07 2020-08-14 西南大学 一种真核生物CRISPR-Cas9双gRNA载体及构建方法
CA3177481A1 (en) 2020-05-08 2021-11-11 David R. Liu Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
CN112280802A (zh) * 2020-05-21 2021-01-29 华中农业大学 基于piggyBac转座子系统制备稳定表达BE4蛋白的猪肾上皮细胞系的方法
IL302830A (en) 2020-11-13 2023-07-01 Egenesis Inc Cells, tissues, organs and animals with one or more genes that have been modified for improved survival and tolerance of a different-sex transplant
EP4426828A1 (en) 2021-11-01 2024-09-11 Tome Biosciences, Inc. Single construct platform for simultaneous delivery of gene editing machinery and nucleic acid cargo
US20250057980A1 (en) 2021-12-22 2025-02-20 Tome Biosciences, Inc. Co-Delivery of a Gene Editor Construct and a Donor Template
CN114438083A (zh) * 2022-01-29 2022-05-06 五邑大学 识别猪PERV基因的sgRNA及其编码DNA和应用
WO2023205744A1 (en) 2022-04-20 2023-10-26 Tome Biosciences, Inc. Programmable gene insertion compositions
KR102921507B1 (ko) * 2022-05-06 2026-02-02 중앙대학교 산학협력단 CRISPR-Cas9을 이용한 정교한 다중 유전체 편집 방법 및 이의 용도
WO2023225670A2 (en) 2022-05-20 2023-11-23 Tome Biosciences, Inc. Ex vivo programmable gene insertion
WO2024020587A2 (en) 2022-07-22 2024-01-25 Tome Biosciences, Inc. Pleiopluripotent stem cell programmable gene insertion
WO2024138194A1 (en) 2022-12-22 2024-06-27 Tome Biosciences, Inc. Platforms, compositions, and methods for in vivo programmable gene insertion
WO2024234006A1 (en) 2023-05-11 2024-11-14 Tome Biosciences, Inc. Systems, compositions, and methods for targeting liver sinusodial endothelial cells (lsecs)
WO2025050069A1 (en) 2023-09-01 2025-03-06 Tome Biosciences, Inc. Programmable gene insertion using engineered integration enzymes
WO2025224107A1 (en) 2024-04-22 2025-10-30 Basecamp Research Ltd Method and compositions for detecting off-target editing
WO2025224182A2 (en) 2024-04-23 2025-10-30 Basecamp Research Ltd Single construct platform for simultaneous delivery of gene editing machinery and nucleic acid cargo

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1250594A4 (en) 2000-01-19 2003-05-07 Biotransplant Inc PORC UNABLE TO TRANSMIT PORCINE ENDOGENEOUS RETROVIRUS, AND USES THEREOF
CN103397019A (zh) * 2003-11-21 2013-11-20 雷维维科公司 干扰rna在生产转基因动物中的用途
EP1582591A3 (en) * 2004-02-27 2005-12-21 Bundesrepublik Deutschland vertreten durch das Bundesminsterium für Gesundheit, dieses vertr. durch das Robert-Koch-Institut Sirna and their use for knock down expression of porcine endogenous retrovirus
NZ539491A (en) * 2005-04-15 2008-04-30 Living Cell Products Pty Ltd Swine population and uses thereof
EP2077329A1 (en) * 2008-01-04 2009-07-08 MWM Biomodels GmbH Transgenic pig with altered incretin function
EP2931899A1 (en) * 2012-12-12 2015-10-21 The Broad Institute, Inc. Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
IL308158A (en) * 2012-12-17 2023-12-01 Harvard College Rna-guided human genome engineering
US10952843B2 (en) * 2014-03-29 2021-03-23 Cormatrix Cardiovascular, Inc. Prosthetic tissue valves
EP4176841A1 (en) * 2013-05-03 2023-05-10 Cormatrix Cardiovascular, Inc. Prosthetic tissue valves
US10188510B2 (en) * 2013-05-03 2019-01-29 Cormatrix Cardiovascular, Inc. Prosthetic tissue valves
US9907649B2 (en) * 2013-05-03 2018-03-06 Cormatrix Cardiovascular, Inc. Prosthetic tissue valves and methods for anchoring same to cardiovascular structures
WO2014197748A2 (en) 2013-06-05 2014-12-11 Duke University Rna-guided gene editing and gene regulation
AU2014312123A1 (en) * 2013-08-29 2016-03-17 Temple University Of The Commonwealth System Of Higher Education Methods and compositions for RNA-guided treatment of HIV infection
CN105899658B (zh) * 2013-12-12 2020-02-18 布罗德研究所有限公司 针对hbv和病毒性疾病以及障碍的crispr-cas系统和组合物的递送、用途和治疗应用
MA41382A (fr) 2015-03-20 2017-11-28 Univ Temple Édition génique basée sur le système crispr/endonucléase à induction par tat
DE102015207944A1 (de) 2015-04-29 2016-11-03 Wacker Chemie Ag Verfahren zur Herstellung organisch modifizierter Aerogele
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
CN105154471A (zh) * 2015-08-11 2015-12-16 南方医科大学珠江医院 低表达或不表达perv的肝细胞的制备方法
AU2016335698B2 (en) 2015-10-08 2022-12-01 President And Fellows Of Harvard College Multiplexed genome editing
WO2017109177A1 (en) 2015-12-24 2017-06-29 Selexis S.A. Improved eukaryotic cells for protein manufacturing and methods of making them
WO2018144546A1 (en) 2017-02-01 2018-08-09 President And Fellows Of Harvard College Methods for increasing efficiency of gene editing in cells
CN116732106A (zh) 2017-04-20 2023-09-12 E开创生物技术股份有限公司 产生基因修改的动物的方法

Similar Documents

Publication Publication Date Title
US12565667B2 (en) CHO integration sites and uses thereof
JP7473136B2 (ja) 多重ゲノム編集
CN108642055B (zh) 能有效编辑猪miR-17-92基因簇的sgRNA
Ata et al. Robust activation of microhomology-mediated end joining for precision gene editing applications
Mangeot et al. Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins
CA2915842C (en) Delivery and use of the crispr-cas systems, vectors and compositions for hepatic targeting and therapy
Aida et al. Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice
CN110892069B (zh) 基于基因组编辑的外显子跳跃诱导方法
CN105492608B (zh) CRISPR-Cas9特异性敲除猪PDX1基因的方法及用于特异性靶向PDX1基因的sgRNA
EP3222728A1 (en) Method for regulating gene expression using cas9 protein expressed from two vectors
CA3060630A1 (en) Methods for generating genetically modified animals
WO2018188571A1 (zh) 基因组编辑系统和方法
JP2018534937A5 (enExample)
US20220145297A1 (en) Rna-targeting cas enzymes
Zhang et al. Comprehensive off-target analysis of dCas9-SAM-mediated HIV reactivation via long noncoding RNA and mRNA profiling
WO2019173248A1 (en) Engineered nucleic acid-targeting nucleic acids
JP7109009B2 (ja) 遺伝子ノックアウト方法
US20220323609A1 (en) Gene editing to correct aneuploidies and frame shift mutations
Pal Gene Editing
Kershanskaya New breakthrough CRISPR/cas9 biotechnology of genome editing for creation of elite crops in Kazakhstan
Mangeot et al. Efficient genome editing in primary cells and in vivo using viral-derived “Nanoblades” loaded with Cas9/sgRNA ribonucleoproteins
CN120866423A (zh) 一种构建猪内源性逆转录病毒失活异种移植供体猪的方法
Ruis et al. SETDB1/ATF7IP regulate the precise genome engineering of HUSH-regulated genes
WO2026017676A1 (en) A novel genomic safe harbor site in the actb locus
El-Nabi et al. Gene evolution and diversity of living organisms theory.